Pharmacological targeting of the mitochondrial phosphatase PTPMT1

Journal of Pharmacology and Experimental Therapeutics

Volumn 333, Issue 2, 2010, Pages 584-592

  Doughty Shenton, Dahlia ^a   Joseph, James D ^a   Zhang, Ji ^b   Pagliarini, David J ^b   Kim, Youngjun ^b   Lu, Danhong ^a   Dixon, Jack E ^b   Casey, Patrick J ^a  

^a DUKE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEXIDINE DIHYDROCHLORIDE; BIGUANIDE DERIVATIVE; CHLORHEXIDINE; MITOCHONDRIAL PROTEIN; MITOCHONDRION PROTEIN TYROSINE PHOSPHATASE 1; PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; COMPETITIVE INHIBITION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME LOCALIZATION; HORMONAL REGULATION; IN VITRO STUDY; INSULIN RELEASE; MOLECULAR LIBRARY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; RAT;

ANIMALS; BIGUANIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; DUAL SPECIFICITY PHOSPHATASE 1; IMMUNOBLOTTING; INSULIN; ISLETS OF LANGERHANS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; PHOSPHORYLATION; RATS; RATS, WISTAR;

EID: 77951030506     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.163329     Document Type: Article

References (38)

1. Alessi DR, Smythe C, and Keyse SM (1993) The human CL100 gene encodes a Tyr/Thr-protein phosphatase, which potently and specifically inactivates MAP kinase and suppresses its activation by oncogenic ras in Xenopus oocyte extracts. Oncogene 8:2015-2020. (Pubitemid 23212436)
2. Alonso A, Sasin J, Bottini N, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J, and Mustelin T (2004) Protein tyrosine phosphatases in the human genome. Cell 117:699-711. (Pubitemid 38748887)
3. Berger P, Schaffitzel C, Berger I, Ban N, and Suter U (2003) Membrane association of myotubularin-related protein 2 is mediated by a pleckstrin homology-GRAM domain and a coiled-coil dimerization module. Proc Natl Acad Sci USA 100:12177-12182. (Pubitemid 37271534)
4. Charles CH, Abler AS, and Lau LF (1992) cDNA sequence of a growth factor-inducible immediate early gene and characterization of its encoded protein. Oncogene 7:187-190.
5. Denu JM, Zhou G, Wu L, Zhao R, Yuvaniyama J, Saper MA, and Dixon JE (1995) The purification and characterization of a human dual-specific protein tyrosine phosphatase. J Biol Chem 270:3796-3803.
6. Ganendren R, Widmer F, Singhal V, Wilson C, Sorrell T, and Wright L (2004) In vitro antifungal activities of inhibitors of phospholipases from the fungal pathogen Cryptococcus neoformans. Antimicrob Agents Chemother 48:1561-1569. (Pubitemid 38544360)
7. Gilbert P and Moore LE (2005) Cationic antiseptics: diversity of action under a common epithet. J Appl Microbiol 99:703-715. (Pubitemid 41399812)
8. Gottlin EB, Xu X, Epstein DM, Burke SP, Eckstein JW, Ballou DP, and Dixon JE (1996) Kinetic analysis of the catalytic domain of human cdc25B. J Biol Chem 271:27445-27449. (Pubitemid 26367303)
9. Guan KL, Broyles SS, and Dixon JE (1991) A Tyr/Ser protein phosphatase encoded by vaccinia virus. Nature 350:359-362. (Pubitemid 21912232)
10. Guan KL and Dixon JE (1990) Protein tyrosine phosphatase activity of an essential virulence determinant in Yersinia. Science 249:553-556. (Pubitemid 20248902)
11. Hendriks WJ, Elson A, Harroch S, and Stoker AW (2008) Protein tyrosine phosphatases: functional inferences from mouse models and human diseases. FEBS J 275:816-830. (Pubitemid 351230202)
12. Jeffrey KL, Camps M, Rommel C, and Mackay CR (2007) Targeting dual-specificity phosphatases: manipulating MAP kinase signaling and immune responses. Nat Rev Drug Discov 6:391-403. (Pubitemid 46705202)
13. Jiang ZX and Zhang ZY (2008) Targeting PTPs with small-molecule inhibitors in cancer treatment. Cancer Metastasis Rev 27:263-272.
14. Johnston PA, Foster CA, Shun TY, Skoko JJ, Shinde S, Wipf P, and Lazo JS (2007) Development and implementation of a 384-well homogeneous fluorescence intensity high-throughput screening assay to identify mitogen-activated protein kinase phosphatase-1 dual-specificity protein phosphatase inhibitors. Assay Drug Dev Technol 5:319-332. (Pubitemid 47067878)
15. Joseph JW, Jensen MV, Ilkayeva O, Palmieri F, Alarcon C, Rhodes CJ, and Newgard CB (2006) The mitochondrial citrate/isocitrate carrier plays a regulatory role in glucose-stimulated insulin secretion. J Biol Chem 281:35624-35632. (Pubitemid 46041293)
16. Koksal AC, Nardozzi JD, and Cingolani G (2009) Dimeric quaternary structure of the prototypical dual-specificity phosphatase VH1. J Biol Chem 284:10129-10137.
17. Krstic D, Krinulovic K, Spasojevic-Tisma V, Joksic G, Momic T, and Vasic V (2004) Effects of digoxin and gitoxin on the enzymatic activity and kinetic parameters of Na+/K+-ATPase. J Enzyme Inhib Med Chem 19:409-415. (Pubitemid 40045501)
18. Lai JP, Bao S, Davis IC, and Knoell DL (2009) Inhibition of the phosphatase PTEN protects mice against oleic acid-induced acute lung injury. Br J Pharmacol 156: 189-200.
19. Maehama T and Dixon JE (1998) The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273:13375-13378. (Pubitemid 28268370)
20. Maehama T, Taylor GS, Slama JT, and Dixon JE (2000) A sensitive assay for phosphoinositide phosphatases. Anal Biochem 279:248-250.
21. Mark JK, Aubin RA, Smith S, and Hefford MA (2008) Inhibition of mitogen-activated protein kinase phosphatase 3 activity by interdomain binding. J Biol Chem 283: 28574-28583.
22. Milburn JL Jr, Hirose H, Lee YH, Nagasawa Y, Ogawa A, Ohneda M, Beltrandel Rio H, Newgard CB, Johnson JH, and Unger RH (1995) Pancreatic β-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids. J Biol Chem 270:1295-1299.
23. Murphy MP and Smith RA (2007) Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol 47:629-656. (Pubitemid 46272141)
24. Myers MP, Stolarov JP, Eng C, Li J, Wang SI, Wigler MH, Parsons R, and Tonks NK (1997) PTEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci USA 94:9052-9057. (Pubitemid 27357780)
25. Pagliarini DJ, Wiley SE, Kimple ME, Dixon JR, Kelly P, Worby CA, Casey PJ, and Dixon JE (2005) Involvement of a mitochondrial phosphatase in the regulation of ATP production and insulin secretion in pancreatic β-cells. Mol Cell 19:197-207. (Pubitemid 41019667)
26. Pagliarini DJ, Worby CA, and Dixon JE (2004) A PTEN-like phosphatase with a novel substrate specificity. J Biol Chem 279:38590-38596.
27. Patterson KI, Brummer T, O'Brien PM, and Daly RJ (2009) Dual-specificity phosphatases: critical regulators with diverse cellular targets. Biochem J 418:475-489.
28. Pulido R and Hooft van Huijsduijnen R (2008) Protein tyrosine phosphatases: dual-specificity phosphatases in health and disease. FEBS J 275:848-866. (Pubitemid 351230203)
29. Ronnebaum SM, Ilkayeva O, Burgess SC, Joseph JW, Lu D, Stevens RD, Becker TC, Sherry AD, Newgard CB, and Jensen MV (2006) A pyruvate cycling pathway involving cytosolic NADP-dependent isocitrate dehydrogenase regulates glucose-stimulated insulin secretion. J Biol Chem 281:30593-30602. (Pubitemid 44582115)
30. Ross MF, Da Ros T, Blaikie FH, Prime TA, Porteous CM, Severina II, Skulachev VP, Kjaergaard HG, Smith RA, and Murphy MP (2006) Accumulation of lipophilic dications by mitochondria and cells. Biochem J 400:199-208. (Pubitemid 44763835)
31. Severina II, Vyssokikh MY, Pustovidko AV, Simonyan RA, Rokitskaya TI, and Skulachev VP (2007) Effects of lipophilic dications on planar bilayer phospholipid membrane and mitochondria. Biochim Biophys Acta 1767:1164-1168.
32. Song M, Park JE, Park SG, Lee do H, Choi HK, Park BC, Ryu SE, Kim JH, and Cho S (2009) NSC-87877, inhibitor of SHP-1/2 PTPs, inhibits dual-specificity phosphatase 26 (DUSP26). Biochem Biophys Res Commun 381:491-495.
33. Streuli M, Krueger NX, Tsai AY, and Saito H (1989) A family of receptor-linked protein tyrosine phosphatases in humans and Drosophila. Proc Natl Acad Sci USA 86:8698-8702. (Pubitemid 20010291)
34. Tabernero L, Evans BN, Tishmack PA, Van Etten RL, and Stauffacher CV (1999) The structure of the bovine protein tyrosine phosphatase dimer reveals a potential self-regulation mechanism. Biochemistry 38:11651-11658. (Pubitemid 129516745)
35. Vang T, Miletic AV, Arimura Y, Tautz L, Rickert RC, and Mustelin T (2008) Protein tyrosine phosphatases in autoimmunity. Annu Rev Immunol 26:29-55.
36. Yi T and Lindner D (2008) The role and target potential of protein tyrosine phosphatases in cancer. Curr Oncol Rep 10:114-121. (Pubitemid 351395471)
37. Yip KW, Ito E, Mao X, Au PY, Hedley DW, Mocanu JD, Bastianutto C, Schimmer A, and Liu FF (2006) Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agent. Mol Cancer Ther 5:2234-2240. (Pubitemid 44530460)
38. Zhang JH, Chung TD, and Oldenburg KR (1999) A simple statistical parameter for use in evaluation and validation of high-throughput screening assays. J Biomol Screen 4:67-73.